caa a22 4500 469121238 CHVBK 20180323133139.0 cr unu---uuuuu 170328e19920301xx s 000 0 eng 10.1007/BF02245415 doi (NATIONALLICENCE)springer-10.1007/BF02245415 Selective effects of triazolam on memory [Elektronische Daten] [H. Weingartner, D. Hommer, R. Lister, K. Thompson, O. Wolkowitz] The effects of a benzodiazepine (triazolam 0.25 and 0.50 mg) on different aspects of cognitive function were assessed. Triazolam impaired free recall and recognition of information presented after drug administration. In contrast to these impairments in explicit memory, a memory function that did not require conscious awareness was not altered by triazolam. Similarly, triazolam did not affect subjects' abilities to access semantic memory. Springer-Verlag, 1992 Benzodiazepine nationallicence Learning nationallicence Memory nationallicence Implicit memory nationallicence Explicit memory nationallicence Semantic memory nationallicence Amnesia nationallicence Weingartner H. Cognition Section, National Institute on Aging, Gerontology Research Center, 21224, Baltimore, MD, USA aut Hommer D. Department of Psychiatry, University of Washington, Seattle, Washington, USA aut Lister R. Laboratory of Clinical Studies, NIAAA, USA aut Thompson K. National Institute of Mental Health, Bethesda, MD, USA aut Wolkowitz O. Department of Psychiatry, University of California at San Francisco, USA aut Psychopharmacology Springer-Verlag 106/3(1992-03-01), 341-345 0033-3158 106:3<341 1992 106 213 https://doi.org/10.1007/BF02245415 text/html Onlinezugriff via DOI 1 research-article jats NATIONALLICENCE 856 40 https://doi.org/10.1007/BF02245415 text/html Onlinezugriff via DOI NATIONALLICENCE 700 1- Weingartner H. Cognition Section, National Institute on Aging, Gerontology Research Center, 21224, Baltimore, MD, USA aut NATIONALLICENCE 700 1- Hommer D. Department of Psychiatry, University of Washington, Seattle, Washington, USA aut NATIONALLICENCE 700 1- Lister R. Laboratory of Clinical Studies, NIAAA, USA aut NATIONALLICENCE 700 1- Thompson K. National Institute of Mental Health, Bethesda, MD, USA aut NATIONALLICENCE 700 1- Wolkowitz O. Department of Psychiatry, University of California at San Francisco, USA aut NATIONALLICENCE 773 0- Psychopharmacology Springer-Verlag 106/3(1992-03-01), 341-345 0033-3158 106:3<341 1992 106 213 Metadata rights reserved Springer special CC-BY-NC licence nationallicence BK010053 XK010053 XK010000 NATIONALLICENCE NATIONALLICENCE NL-springer